-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Thor Medical ASA - Share capital increase in relation to the Private Placement and the PrimaryBid Offering is registered
26 Jun 2025 14:24 CEST
Issuer
Thor Medical ASA
26.6.2025 14:24:32 CEST | Thor Medical ASA | Total number of voting rights and
capital
Oslo, Norway, 26 June 2025: Reference is made to stock exchange announcement by
Thor Medical ASA (the "Company") on 18 June 2025 regarding the successful
completion of a private placement of a total of 30,000,000 new shares in the
Company raising a total of NOK 75 million in gross proceeds (the "Private
Placement") and a retail offering of a total of 4,577,399 new shares raising a
total of approx. NOK 11.4 million in gross proceeds (the "PrimaryBid Offering").
The share capital increase relating to the Private Placement and the share
capital increase relating to the PrimaryBid Offering is now registered with the
Norwegian Register of Business Enterprises. The Company's share capital is after
the registration NOK 69,797,184 divided into 348,985,920 shares. Each share has
a nominal value of NOK 0.20 and represents one vote in the Company's general
meeting.
DISCLOSURE REGULATION
This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.
CONTACTS
Brede Ellingsæter, CFO & COO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18581837/6253/Download%20announce
ment%20as%20PDF.pdf
More information:
Access the news on Oslo Bors NewsWeb site
Source
Thor Medical ASA
Provider
Oslo Børs Newspoint
Company Name
THOR MEDICAL ASA
ISIN
NO0010597883
Symbol
TRMED
Market
Euronext Oslo Børs